# Changes in myocardial blood flow and microvascular resistance in patients with coronary artery disease undergoing transcatheter aortic valve implantation

**Authors:** Eron Yones, Rebecca Gosling, Daniel Taylor, Tom Alexander Howard Newman, Mark Sammut, Saadia Aslam, Javaid Iqbal, Muhammad Aetesam-ur-Rahman, Kenneth Morgan, Amir Aziz, Melanie Neville, Ever Grech, Paul D Morris, Julian Gunn

PMC · DOI: 10.1136/openhrt-2025-003621 · 2025-12-30

## TL;DR

This study shows that TAVI improves coronary blood flow in patients with aortic stenosis and coronary artery disease, likely due to reduced heart workload.

## Contribution

The novel finding is that TAVI increases coronary flow reserve primarily through reduced resting blood flow and myocardial remodelling, not microvascular resistance changes.

## Key findings

- Coronary flow reserve increased significantly 6 months after TAVI.
- Resting and stress myocardial blood flow decreased significantly after TAVI.
- Left ventricular mass reduced significantly following TAVI.

## Abstract

Severe aortic stenosis (AS) causes a pathophysiological cascade, which impairs myocardial blood flow. This effect is exacerbated in the presence of coronary disease (CAD). Treatment with transcatheter aortic valve implantation (TAVI) may promote reversal of these pathophysiological conditions.

We performed multimodality assessment of cardiac physiology in patients with AS and concurrent CAD requiring percutaneous coronary intervention, prior to and 6 months after undergoing TAVI. Techniques include: coronary angiography and bolus thermodilution-derived indices of microvascular function (coronary flow reserve (CFR); index of microcirculatory resistance (IMR)); stress perfusion cardiac magnetic resonance (CMR) imaging, which was used to measure changes in global myocardial blood flow (MBF) and left ventricular mass (LVM), and computed resting and hyperaemic vessel specific absolute coronary flow (aCBF) and microvascular resistance (MVR) using a computational model of coronary physiology.

Data were obtained for seven patients (10 vessels). CFR increased from 1.53 (1.2–1.7) to 2.35 (2.0–2.7) (p=0.037) 6 months post-TAVI. There was a 33% reduction in resting aCBF from 218 mL/min to 146 mL/min (p=0.004). On CMR, resting MBF fell 37% from 3.0±0.98 mL/min/g to 1.9±0.7 mL/min/g (p=0.033) and stress MBF fell 25% from 3.6±0.57 mL/min/g to 2.7±0.7 mL/min/g (p=0.004). Indexed LVM regressed from 79±14 g/m2 to 71±16 g/m2 (p=0.006). MVR remained unchanged.

CFR increased following TAVI. The mechanism for this was a significant reduction in resting coronary blood flow measured with CMR and modelled computationally. The unchanged MVR and IMR suggest that resting blood flow reduces due to reduced myocardial demand and myocardial remodelling, rather than changes in resistance.

## Linked entities

- **Diseases:** aortic stenosis (MONDO:0042981), coronary artery disease (MONDO:0005010)

## Full-text entities

- **Diseases:** AS (MESH:D001024), coronary artery disease (MESH:D003324), myocardial remodelling (MESH:D064752), CAD (MESH:D003327)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12766762/full.md

---
Source: https://tomesphere.com/paper/PMC12766762